Development Level

Tbio 23 | 10,625
Tchem 12 | 1,890
Tclin 3 | 602
Tdark 3 | 7,003

IMPC Term

decreased total body fat amoun... 3 | 186
increased grip strength 3 | 83
abnormal rib morphology 2 | 28
decreased bone mineral content 2 | 157
immune system phenotype 2 | 17
increased circulating alkaline... 2 | 119
increased mean corpuscular hem... 2 | 93
increased startle reflex 2 | 38
preweaning lethality, complete... 2 | 633
thrombocytopenia 2 | 46
abnormal bone mineralization 1 | 55
abnormal coat/hair pigmentatio... 1 | 54
abnormal craniofacial morpholo... 1 | 12
abnormal cranium morphology 1 | 32
abnormal embryo size 1 | 112
abnormal eyelid morphology 1 | 6
abnormal facial morphology 1 | 9
abnormal head shape 1 | 4
abnormal head size 1 | 1
abnormal snout morphology 1 | 18
abnormal thoracic vertebrae mo... 1 | 16
abnormal vertebral arch morpho... 1 | 9
anophthalmia 1 | 20
cardiovascular system phenotyp... 1 | 35
cleft palate 1 | 6
craniofacial phenotype 1 | 9
decreased alpha-beta T cell nu... 1 | 12
decreased blood urea nitrogen ... 1 | 31
decreased body length 1 | 108
decreased body weight 1 | 174
decreased bone mineral density 1 | 126
decreased circulating LDL chol... 1 | 37
decreased circulating alanine ... 1 | 53
decreased circulating aspartat... 1 | 27
decreased circulating triglyce... 1 | 83
decreased grip strength 1 | 123
decreased lean body mass 1 | 195
decreased lumbar vertebrae num... 1 | 62
decreased prepulse inhibition 1 | 52
decreased rib number 1 | 59
decreased spleen weight 1 | 13
decreased threshold for audito... 1 | 32
embryonic lethality prior to t... 1 | 187
facial cleft 1 | 3
increased circulating HDL chol... 1 | 63
increased circulating LDL chol... 1 | 15
increased circulating phosphat... 1 | 24
increased circulating potassiu... 1 | 31
increased exploration in new e... 1 | 56
increased gamma-delta T cell n... 1 | 16
increased mean corpuscular vol... 1 | 91
increased or absent threshold ... 1 | 128
increased sacral vertebrae num... 1 | 62
mydriasis 1 | 9
prenatal lethality prior to he... 1 | 64
preweaning lethality, incomple... 1 | 260
short tibia 1 | 82
small adrenal glands 1 | 15

Disease

ovarian cancer 28 | 8,492
osteosarcoma 23 | 7,933
medulloblastoma, large-cell 21 | 6,234
psoriasis 20 | 6,685
Cancer 19 | 2,346
atypical teratoid / rhabdoid tumor 17 | 4,369
glioblastoma 17 | 5,572
lung cancer 16 | 4,473
malignant mesothelioma 12 | 3,163
non-small cell lung cancer 12 | 2,798
diabetes mellitus 11 | 1,663
pilocytic astrocytoma 11 | 3,086
Multiple myeloma 10 | 1,328
lung carcinoma 10 | 2,844
subependymal giant cell astrocytoma 10 | 2,287
invasive ductal carcinoma 9 | 2,950
lung adenocarcinoma 9 | 2,714
oligodendroglioma 9 | 2,849
colon cancer 8 | 1,475
ulcerative colitis 8 | 2,087
Alzheimer's disease 7 | 644
Waldenstrons macroglobulinemia 7 | 765
adult high grade glioma 7 | 2,148
astrocytic glioma 7 | 2,241
astrocytoma 7 | 1,493
dermatomyositis 7 | 967
intraductal papillary-mucinous neoplasm (IPMN) 7 | 3,289
juvenile dermatomyositis 7 | 1,189
medulloblastoma 7 | 1,524
pancreatic ductal adenocarcinoma liver metastasis 7 | 1,795
Breast cancer 6 | 3,099
cystic fibrosis 6 | 1,670
group 3 medulloblastoma 6 | 2,254
interstitial cystitis 6 | 2,299
pancreatic cancer 6 | 2,300
pediatric high grade glioma 6 | 2,712
primitive neuroectodermal tumor 6 | 3,031
tuberculosis 6 | 1,563
Carcinoma 5 | 2,147
Pick disease 5 | 1,893
Rheumatoid Arthritis 5 | 1,171
cutaneous lupus erythematosus 5 | 1,056
esophageal adenocarcinoma 5 | 737
intraductal papillary-mucinous adenoma (IPMA) 5 | 2,956
posterior fossa group A ependymoma 5 | 1,511
Amyotrophic Lateral Sclerosis 4 | 432
Crohn's disease 4 | 304
Multiple Sclerosis 4 | 498
Parkinson's disease 4 | 364
Toxic encephalopathy 4 | 131
active Crohn's disease 4 | 918
acute quadriplegic myopathy 4 | 1,157
atypical teratoid/rhabdoid tumor 4 | 1,095
breast carcinoma 4 | 1,614
ductal carcinoma in situ 4 | 1,745
ependymoma 4 | 2,514
intraductal papillary-mucinous carcinoma (IPMC) 4 | 2,988
pituitary cancer 4 | 1,972
spina bifida 4 | 1,064
Colorectal Neoplasms 3 | 217
Down syndrome 3 | 548
Hypertensive disease 3 | 193
Intellectual disability 3 | 573
Neurodegenerative disease 3 | 383
Obesity 3 | 616
Peripheral Neuropathy 3 | 303
Stomach Neoplasms 3 | 282
chronic lymphosyte leukemia 3 | 232
chronic rhinosinusitis 3 | 512
group 4 medulloblastoma 3 | 1,875
nasopharyngeal carcinoma 3 | 1,056
primary pancreatic ductal adenocarcinoma 3 | 1,271
tuberculosis and treatment for 3 months 3 | 327
tuberculosis and treatment for 6 months 3 | 686
Atherosclerosis 2 | 275
Bipolar Disorder 2 | 266
Cerebrovascular disease 2 | 231
Duchenne muscular dystrophy 2 | 602
Hyperalgesia 2 | 71
Kidney disease 2 | 397
Liver carcinoma 2 | 217
Mammary Neoplasms 2 | 410
Migraine 2 | 79
Myocardial Ischemia 2 | 169
Peripheral T-cell lymphoma 2 | 24
Pontocerebellar hypoplasia 2 | 29
Schizophrenia 2 | 503
acute myeloid leukemia 2 | 785
autosomal dominant Emery-Dreifuss muscular dystrophy 2 | 499
fibroadenoma 2 | 557
gastric cancer 2 | 436
gastric carcinoma 2 | 832
glioblastoma multiforme 2 | 347
hepatocellular carcinoma 2 | 550
inflammatory breast cancer 2 | 404
primary Sjogren syndrome 2 | 789
progressive supranuclear palsy 2 | 674
sonic hedgehog group medulloblastoma 2 | 1,482
systemic lupus erythematosus 2 | 172
urothelial carcinoma 2 | 318

Tissue

Blood and immune system 41 | 17,995
Cardiovascular System 41 | 17,958
Digestive Tract 41 | 18,473
Endocrine System 41 | 18,512
Female tissues 41 | 18,647
Liver and Pancreas 41 | 18,136
Male tissues 41 | 17,969
Nervous System 41 | 18,561
Respiratory system 41 | 17,484
Urinary Tract 41 | 18,444
Skin and soft tissues 40 | 18,115

Target Family

Non-IDG 24 | 11,969
Enzyme 7 | 4,146
Kinase 5 | 634
Transcription Factor 3 | 1,400
Epigenetic 2 | 242

GO Process

negative regulation of protein... 41 | 41
transcription, DNA-templated 1,779 | 1,779
regulation of transcription, D... 1,170 | 1,170
signal transduction 969 | 969
positive regulation of transcr... 845 | 845
G-protein coupled receptor sig... 666 | 666
negative regulation of transcr... 620 | 620
apoptotic process 506 | 506
positive regulation of transcr... 504 | 504
negative regulation of transcr... 483 | 483
multicellular organism develop... 456 | 456
positive regulation of cell pr... 451 | 451
cell differentiation 442 | 442
negative regulation of apoptot... 440 | 440
innate immune response 410 | 410
cell adhesion 409 | 409
immune response 398 | 398
negative regulation of cell pr... 379 | 379
inflammatory response 371 | 371
viral process 368 | 368
spermatogenesis 365 | 365
cell proliferation 358 | 358
protein transport 356 | 356
intracellular signal transduct... 355 | 355
cell division 330 | 330
regulation of transcription fr... 324 | 324
protein phosphorylation 320 | 320
response to drug 297 | 297
positive regulation of apoptot... 292 | 292
nervous system development 275 | 275
transcription from RNA polymer... 272 | 272
cell surface receptor signalin... 267 | 267
protein ubiquitination 260 | 260
transport 257 | 257
cell-cell signaling 249 | 249
regulation of immune response 247 | 247
positive regulation of gene ex... 242 | 242
mitotic nuclear division 241 | 241
MAPK cascade 238 | 238
chemical synaptic transmission 238 | 238
mRNA splicing, via spliceosome 219 | 219
angiogenesis 218 | 218
small GTPase mediated signal t... 215 | 215
translation 215 | 215
rRNA processing 209 | 209
intracellular protein transpor... 205 | 205
cellular response to DNA damag... 201 | 201
cell cycle 200 | 200
proteasome-mediated ubiquitin-... 200 | 200
proteolysis 199 | 199
visual perception 198 | 198
DNA repair 196 | 196
extracellular matrix organizat... 193 | 193
regulation of apoptotic proces... 190 | 190
brain development 183 | 183
positive regulation of cell mi... 181 | 181
protein polyubiquitination 181 | 181
in utero embryonic development 178 | 178
Fc-epsilon receptor signaling ... 176 | 176
Wnt signaling pathway 175 | 175
ion transmembrane transport 174 | 174
protein homooligomerization 173 | 173
heart development 170 | 170
positive regulation of ERK1 an... 170 | 170
blood coagulation 169 | 169
cell migration 168 | 168
regulation of cell proliferati... 167 | 167
protein autophosphorylation 166 | 166
response to hypoxia 164 | 164
mRNA processing 162 | 162
negative regulation of canonic... 162 | 162
protein folding 162 | 162
T cell receptor signaling path... 161 | 161
response to lipopolysaccharide 161 | 161
defense response to virus 160 | 160
RNA splicing 158 | 158
aging 158 | 158
positive regulation of I-kappa... 158 | 158
axon guidance 157 | 157
homophilic cell adhesion via p... 155 | 155
sensory perception of smell 155 | 155
ER to Golgi vesicle-mediated t... 151 | 151
interferon-gamma-mediated sign... 150 | 150
protein ubiquitination involve... 150 | 150
transcription initiation from ... 150 | 150
ubiquitin-dependent protein ca... 149 | 149
DNA replication 144 | 144
adaptive immune response 139 | 139
cell cycle arrest 139 | 139
receptor-mediated endocytosis 139 | 139
skeletal system development 136 | 136
regulation of cell shape 135 | 135
regulation of small GTPase med... 134 | 134
G2/M transition of mitotic cel... 133 | 133
oxidation-reduction process 133 | 133
positive regulation of cytosol... 133 | 133
protein stabilization 133 | 133
sensory perception of sound 132 | 132
positive regulation of NF-kapp... 131 | 131
antigen processing and present... 130 | 130
type I interferon signaling pa... 130 | 130

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Guanine nucleotide-binding protein-like 3-like protein GNL3L Tbio Non-IDG -0.65739 5.74 119
Putative peripheral benzodiazepine receptor-related protein TSPO Tbio Non-IDG -3.04986 2078.3 186
Calcineurin B homologous protein 1 CHP1 Tbio Non-IDG -1.60562 34.9 108
Sentrin-specific protease 2 SENP2 Tbio Enzyme -0.25795 1.43 271
Histone deacetylase 8 HDAC8 Tclin Epigenetic -2.36549 229.4 425
Nucleoredoxin NXN Tbio Non-IDG -2.51638 323.4 88
BAG family molecular chaperone regulator 5 BAG5 Tbio Non-IDG -1.25287 17.6 316
Vacuolar protein sorting-associated protein 28 homolog VPS28 Tbio Non-IDG -1.28083 15.2 86
Nucleolar GTP-binding protein 1 GTPBP4 Tbio Non-IDG -3.16978 1443.3 95
Beta-arrestin-1 ARRB1 Tchem Non-IDG -2.57742 366.3 416